Metropolis Healthcare Limited launches an advanced diagnostic laboratory in Kunnamkulam, Kerala

 

~ Extending high-quality testing services to patients with latest & innovative diagnostic technologies~ 

Kunnamkulam, Kerala, 14^th July 2023: Metropolis Healthcare Limited, India’s leading diagnostic service provider announced the launch of an advanced diagnostic testing centre in Kunnamkulam, a prominent business town in Kerala’s Thrissur district. This new cutting-edge diagnostic testing laboratory can process up to 200 samples per day, ranging from basic day-to-day pathology tests to complex molecular diagnostic tests.

Inaugurating the state-of-the art laboratory, Shri. A C Moideen, MLA commented: “I am pleased to welcome Metropolis’s new and advanced diagnostic centre to serve patients in Kunnamkulam. As people are becoming more conscious of their health, preventive screening and timely diagnosis is equally important in order to avoid complications of later stages of any disease, and the presence of such a reputed national diagnostic chain in the city is reassuring. With this, I urge the citizens of the city to invest in essential testing for themselves and their families on a regular basis.”

Mr. Surendran Chemmenkottil, Chief Executive Officer, Metropolis Healthcare Limited said: “The opening of this lab in Kunnamkulam is in line with Metropolis’ mission to expand our reach in Tier 2 and Tier 3 towns in core geographic locations where the company has strong brand recognition. Metropolis has grown its presence in Kerala over the years, with over 25 processing laboratories and more than 70 patient collection centres serving a network of hospitals and doctors throughout the state. With the opening of the new processing lab, we hope to provide high-quality diagnostic testing services and reliable reports to clinicians and patients in Kunnamkulam and nearby areas in a timely manner.”

Dr Xavier Thomas MD Pathology, Chief of Laboratory - Metropolis Healthcare Limited, commented: “Metropolis over the years has been known for its specialized testing capabilities in addition to routine pathology tests. We have the most diverse test menu under our roof and are constantly focused on bringing more and more test menu year after year. And we look forward to providing these different kinds of tests to doctors in order to aid them in making effective clinical decisions, as well as assisting patients in all phases of disease diagnosis with accurate reports.”

With decades of experience, Metropolis Laboratories have earned numerous quality accreditations, both in India and internationally. Metropolis has conscientiously developed the Indian Reference Range for an extensive test menu, which is now being used by thousands of laboratories across the country.

The new Sudharma Metropolis Healthcare Limited lab is located at CTG Towers, Opp.Town Hall, Near Bus stand, Kunnamkulam, Kerala - 680523.

About Metropolis Healthcare Limited:

Established in 1981, Metropolis Healthcare Limited is a leading diagnostics company in India with a widespread presence in 20 states & 220 cities. Internationally, the company has presence in South Asia, Africa, and the Middle East. Metropolis touches millions of lives each year by providing actionable health insights to patients and doctors. Metropolis offers a comprehensive range of 4,000 plus tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. The company is empowered with a robust network of over 175 labs, 3675 collection centres and 10000+ touch points. Metropolis’ commitment to quality and accuracy in each test is reinforced by its consistent CAP proficiency score of more than 98% over the past decade, which places it amongst the top 1% laboratories worldwide for quality assurance. Metropolis philosophy rests on the pillars of technological superiority, a warm patient centric approach and reliable diagnostic reports. For more information, please visit www.metropolisindia.com or follow us on Twitter, Facebook, or LinkedIn.